The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1101/2021.05.30.21257945
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The Digital Analytic Patient Reviewer (DAPR) for COVID-19 Data Mart Validation

Abstract: Objective: To provide high-quality data for COVID-19 research, we validated COVID-19 clinical indicators and 22 associated computed phenotypes, which were derived by machine learning algorithms, in the Mass General Brigham (MGB) COVID-19 Data Mart. Materials and Methods: Fifteen reviewers performed a manual chart review for 150 COVID-19 positive patients in the data mart. To support rapid chart review for a wide range of target data, we offered the Digital Analytic Patient Reviewer (DAPR). DAPR is a web-based … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…(RISC) department, we have been using a categorical data timeline for phenotype validation. We learned from experience that naively applying timelines can cause many problems and undo its benefits 36 . The complexity of healthcare data poses challenges.…”
Section: In the Mass General Brigham (Mgb) Research Information Scien...mentioning
confidence: 99%
See 1 more Smart Citation
“…(RISC) department, we have been using a categorical data timeline for phenotype validation. We learned from experience that naively applying timelines can cause many problems and undo its benefits 36 . The complexity of healthcare data poses challenges.…”
Section: In the Mass General Brigham (Mgb) Research Information Scien...mentioning
confidence: 99%
“…We learned from experience that naively applying timelines can cause many problems and undo its benefits. 36 The complexity of health care data poses challenges. For example, diseases may be acute or chronic, and treatment can vary in length and intensity.…”
Section: Introductionmentioning
confidence: 99%